The role of magnetic resonance imaging of the heart in the diagnosis of proarrhythmogenic mitral valve prolapse
Abstract
Mitral valve prolapse
is one of the most common valvular disease in general population. Rare
complications of mitral valve prolapse are malignant ventricular arrhythmias
and sudden cardiac death. Identification of specific subsets of individuals
with mitral valve prolapse and arrhythmic risk is clinically relevant.
Nowadays
cardiovascular magnetic resonance is widely used in routine practice due to its
possibilities to estimate the heart anatomy and function and noninvasively
characterize myocardium. In this report we demonstrate how cardiovascular
magnetic resonance can be employed stratification of sudden cardiac death in
several cases of mitral valve prolapse.
Keywords:mitral valve prolapse; mitral annular disjunction; arrhythmias; sudden cardiac death; cardiovascular magnetic resonance; myocardium mapping
Funding. This study was supported by research project of the Lomonosov Moscow
State University.
Conflict of
interest. The authors declare no conflict of interest.
For citation: Mershina E.A., Ryzhkova E.V., Chumakova O.S., Myasnikov R.P., Sinitsyn
V.E. The role of magnetic resonance imaging of the heart in the diagnosis of
proarrhythmogenic mitral valve prolapse. Clinical and Experimental Surgery.
Petrovsky Journal. 2023; 11 (3): 29–37. DOI: https://doi.org/10.33029/2308-1198-2023-11-3-29-37 (in Russian)
References
1. Freed L.A., Levy D., Levine R.A., et al. Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med. 1999; 341: 1–7.
2. Devereux R.B., Jones E.C., Roman M.J., et al. Prevalence and correlates of mitral valve prolapse in a population-based sample of American Indians: the strong heart study. Am J Med. 2001; 111: 679–85.
3. Nalliah C.J., Mahajan R., Elliott A.D., et al. Mitral valve prolapse and sudden cardiac death: a systematic review and meta-analysis. Heart. 2019; 105: 144–51.
4. Shirobokikh O.E., Bylova N.A. Mitral valve prolapse and sudden cardiac death: who is at risk? Arkhiv vnutrenney meditsiny [Archives of Internal Medicine]. 2016; 6 (3): 25–9. (in Russian)
5. Sabbag A., Essayagh B., Barrera J.D.R., et al. EHRA expert consensus statement on arrhythmic mitral valve prolapse and mitral annular disjunction complex in collaboration with the ESC Council on Valvular Heart Disease and the European Association of Cardiovascular Imaging endorsed by the Heart Rhythm Society, by the Asia Pacific Heart Rhythm Society, and by the Latin American Heart Rhythm Society. Europace. 2022; 24 (12): 1981–2003.
6. Bains S., Tester D.J., Asirvatham S.J., et al. A novel truncating variant in FLNC-encoded filamin C may serve as a proarrhythmic genetic substrate for arrhythmogenic bileaflet mitral valve prolapse syndrome. Mayo Clin Proc. 2019; 94 (5): 906–13. DOI: https://doi.org/10.1016/j.mayocp.2018.11.028 Epub 2019 Mar 29.
7. Roselli C., Yu M., Nauffal V., et al. Genome-wide association study reveals novel genetic loci: a new polygenic risk score for mitral valve prolapse. Eur Heart J. 2022; 43 (17): 1668–80.
8. Malev E.G., Reeva S.V., Zemtsovsky E.V. Mitral valve prolapse. Kardiologiya: novosti, mneniya, obuchenie [Cardiology: News, Opinions, Training]. 2016; (1): 39–47. (in Russian)
9. Toomer K.A., Yu M., Fulmer D., et al. Primary cilia defects causing mitral valve prolapse. Sci Transl Med. 2019; 11 (493): eaax0290.
10. Bains, S., Tester D.J., Asirvatham S.J., Noseworthy P.A., et al. A Novel truncating variant in FLNC-encoded filamin C may serve as a proarrhythmic genetic substrate for arrhythmogenic bileaflet mitral valve prolapse syndrome. Mayo Clin Proc. 2019; 94: 906–13.
11. Barlow J.B., Pocock W.A., Marchand P., Denny M. The significance of late systolic murmurs. Am Heart J. 1963; 66: 443–52.
12. Zoghbi W.A., Adams D., Bonow R.O., et al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2017; 30 (4): 303–71.
13. Freed L.A., Benjamin E.J., Levy D., et al. Mitral valve prolapse in the general population. J Am Coll Cardiol. 2002; 40: 1298–304.
14. Muthukumar L., Rahman F., Jan M.F., et al. The Pickelhaube sign: novel echocardiographic risk marker for malignant mitral valve prolapse syndrome. JACC Cardiovasc Imaging. 2017; 10 (9): 1078–80.
15. Bennett S., Thamman R., Griffiths T., et al. Mitral annular disjunction: a systematic review of the literature. Echocardiography. 2019; 36 (8): 1549–58.
16. Essayagh B., Sabbag A., Antoine C., et al. Presentation and outcome of arrhythmic mitral valve prolapse. J Am Coll Cardiol. 2020; 76 (6): 637–49.
17. Perazzolo M.M., Basso C., De Lazzari M., et al. Morphofunctional abnormalities of mitral annulus and arrhythmic mitral valve prolapse. Circ Cardiovasc Imaging. 2016; 9 (8): e005030.
18. Carmo P., Andrade M.J., Aguiar C., Rodrigues R., Gouveia R., Silva J.A. Mitral annular disjunction in myxomatous mitral valve disease: a relevant abnormality recognizable by transthoracic echocardiography. Cardiovasc Ultrasound. 2010; 8: 53.
19. Dejgaard L.A., Skjølsvik E.T., Lie O.H., et al. The mitral annulus disjunction arrhythmic syndrome. J Am Coll Cardiol. 2018; 72 (14): 1600–9.
20. Delling F.N., Aung S., Vittinghoff E., et al. Antemortem and post-mortem characteristics of lethal mitral valve prolapse among all countywide sudden deaths. JACC Clin Electrophysiol. 2021; 7 (8): 1025–34.
21. Posokhov I.N. Mitral regurgitation and flexible mitral valve in the practice of a therapist. Klinicheskiy vestnik FMBTs imeni A.I. Burnazyana [Clinical Bulletin of the FMBC named after A.I. Burnazyan]. 2022; (1): 45–56. (in Russian).
22. Tung R., Bauer B., Schelbert H., Lynch J.P. 3rd, Auerbach M., et al. Incidence of abnormal positron emission tomography in patients with unexplained cardiomyopathy and ventricular arrhythmias: the potential role of occult inflammation in arrhythmogenesis. Heart Rhythm. 2015; 12 (12): 2488–98.
23. Miller M.A., Adams D.H., Pandis D., et al. Hybrid positron emission tomography/magnetic resonance imaging in arrhythmic mitral valve prolapse. JAMA Cardiol. 2020; 5 (9): 1000–5.
24. Perazzolo Marra M., Basso C., De Lazzari M., Rizzo S., et al. Morphofunctional abnormalities of mitral annulus and arrhythmic mitral valve prolapse. Circ Cardiovasc Imaging. 2016; 9 (8): e005030.
25. Grigioni F., Enriquez-Sarano M., Ling L., et al. Sudden death in mitral regurgitation due to flail leaflet. J Am Coll Cardiol. 1999; 34: 2078–85.
26. Antoine C., Benfari G., Michelena H.I., et al. Clinical outcome of degenerative mitral regurgitation: critical importance of echocardiographic quantitative assessment in routine practice. Circulation. 2018; 138: 1317–26.
27. Singh S.N., Fletcher R.D., Fisher S.G., et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival trial of antiarrhythmic therapy in congestive heart failure. N Engl J Med. 1995; 333: 77–82.
28. Revishvili A.Sh., Neminushchiy N.M., Batalov R.E., et al. All-Russian clinical guidelines for managing the risk of sudden cardiac arrest and sudden cardiac death, prevention and first aid. Vestnik aritmologii [Bulletin of Arrhythmology]. 2017; (89): 2–104. (in Russian)
29. Vahanian A., Beyersdorf F., Praz F., et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2022; 43 (7): 561–632.